openPR Logo
Press release

Latest news reports on the IPDiA-Leti Common Lab results

04-30-2012 11:38 AM CET | Industry, Real Estate & Construction

Press release from: IPDiA

Leti and IPDiA are proud to unveil a new worldwide record in capacitance density

GRENOBLE, France – April 10, 2012 – CEA-Leti and IPDiA report to overcome a crucial step toward market deployment of a new generation of 3D high-density capacitor achieving 550nF/mm2.

In less than two years, CEA-Leti and IPDiA, within the PRIIM project funded by OSEO, are successfully developing a new process based on deposition of atomic medium-K dielectric layers into the aggressive architectures of IPDiA’s 3D dimensional metal-insulator-metal capacitors. The atomic layer deposition (ALD) is a key process technology to enable conformal coating of high aspect ratio surfaces and to enable exact thickness control on atomic level. A capacitance density of 550nF/mm2 has been obtained by keeping leakage current and parasitic levels as low as in the 250nF/mm2 PICS3 product.

The “PICS” high-density capacitors are using the third dimension to substantially increase the capacitor surface and thus its capacitance without increasing the capacitor footprint. This technology demonstrates inherent good performance with very high stability (temperature, voltage, ageing), superior reliability and very low parasitic elements (ESR, ESL). It is an excellent alternative to discrete component (MLCC and tantalum capacitors) as it shows better performance in a much smaller volume.
The high performance, stability and reliability, combined with very high capacitance density provide lots of interest for customers in High Reliability applications such as the medical, harsh environment, automotive, communication, industrial, and defense/aerospace markets. Targeted applications are for instance DC/DC converter and decoupling functions within limited space: IC decoupling, Mems, Sensors, Memory stick, Smartcard.
IPDiA and CEA-Leti are continuing their developments to stabilize the process and to fasten the market deployment; the next step is now to achieve the ambitious 1μF/mm2.

IPDiA unveiled its results at the Device Packaging Conference in Scottdale (USA) last month.

About IPDiA
Founded in June 2009, IPDiA is a leader in passive-components integration on silicon with a global offer for miniaturization that features high-level technological and economic performance. The company is mainly focused on the following fields: healthcare, lighting, communication, defence, aerospace, industry and automotive.
The company is based in Caen, France:
For more information, visit www.ipdia.com

About CEA-Leti
Leti is an institute of CEA, a French research-and-technology organization with activities in energy, IT, healthcare, defence and security. Leti is focused on creating value and innovation through technology transfer to its industrial partners. It specializes in nanotechnologies and their applications, from wireless devices and systems, to biology, healthcare and photonics. NEMS and MEMS are at the core of its activities. An anchor of the MINATEC campus, CEA-Leti operates 8,000-m² of state-of-the-art clean room space on 200mm and 300mm wafer platforms. It employs 1,400 scientists and engineers and hosts more than 190 Ph.D. students and 200 assignees from partner companies. CEA-Leti owns more than 1,700 patent families.
For more information, visit www.leti.fr.

IPDiA
2 Rue Girafe
14000 Caen
FRANCE

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest news reports on the IPDiA-Leti Common Lab results here

News-ID: 219288 • Views:

More Releases from IPDiA

IPDiA and TecStar/Macnica announce Distribution Agreement for Japan
IPDiA is pleased to announce that a distribution agreement has been signed with TecStar Company (division company of Macnica, Inc.) to offer a wider availability of IPDiA portfolio of high performance silicon passive components in Japan. After Americas and Europe, IPDiA strengthens its sales network in Asia with one of the leaders in electronic components. This agreement implies the distribution of the wide range of IPDiA silicon capacitors and passive networks
Advanced market chip-set solution for RF ISM range 868MHz & 915MHz
Advanced market chip-set solution for RF ISM range 868MHz & 915MHz
IPDiA, a leading supplier of Silicon passive components, today introduced a new generation of RF companion chip products, expanding its product portfolio in high-density Integrated Passive Devices. ASPICS320.604, 605& 606 Integrated Passive Devices (RF ISM range 868MHz & 915MHz) are specifically designed for use with the SX1211 transceiver from Semtech, a leading supplier of analog and mixed-signal semiconductors. The RF design is well known for its complexity and multi influence on

More Releases for Leti

Neuromorphic Computing: Transforming AI with Brain-Like Energy Efficiency | Top …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030. The global neuromorphic computing market is expected to exhibit a CAGR of 91.5% during the forecast period (2024-2031). Neuromorphic computing refers to brain-inspired hardware and algorithms-such as spiking neural networks (SNNs)-designed to mimic the structure and functionality of biological neurons and synapses. These
France's $19.4 Billion Biomanufacturing Surge | Continuous Bioprocessing, AI-Dri …
Continuous Bioprocessing Market in France | The Future of Innovation, Investment, and Sector Growth With the biopharmaceutical and pharmaceutical sectors racing ahead at a breakneck speed, one of the areas of considerable innovation and promise is continuous bioprocessing. This technology, instead of traditional batch processing, offers substantial gains in efficiency, cost savings, and scalability. France, as a biomanufacturing power in Europe, is becoming a center in the development and adoption of continuous
Food Allergy Immunotherapies Market 2022 Precise Outlook - Anergis, HAL Allergy …
Food Allergy Immunotherapies Market Report is an in-depth study of the current state aimed at the major drivers, market strategies, and key player's growth. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the leading competitors operating in the market on a universal and local scale. The structured analysis contains graphical as well as a diagrammatic representation
What's Operating the Allergy Immunotherapy Market, Worldwide Industry Growth?  …
Increasing incidences of allergies and inefficient treatment methodologies, such as pharmacotherapy, for controlling the occurrence rate of allergies are fuelling adoption of allergy immunotherapy, which is deemed as a designated cure for various types of allergies. A notable shift of patients and healthcare providers towards allergy immunotherapy has been observed, owing to its competency to change the course of the disease and improve the immunological resistance. Development of new products to
Allergy Immunotherapies (Allergy Immunotherapy) Market Research Report, Global F …
UpMarketResearch offers a latest published report on “Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report focuses on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Free Exclusive PDF Sample Copy of This Report @ https://www.upmarketresearch.com/home/requested_sample/27936 Allergy Immunotherapies (Allergy Immunotherapy) Market research report delivers a close watch
Competitive Scenario: Allergy Immunotherapy Market By Key Players: HAL, WOLW Pha …
Qyresearchreports include new market research report Allergy Immunotherapy to its huge collection of research reports. Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change